THE DESCRIPTION AND PREDICTION OF ANTIHYPERTENSIVE DRUG RESPONSE - AN INDIVIDUALIZED APPROACH

被引：11

作者：

DONNELLY, R

MEREDITH, PA

ELLIOTT, HL

机构：

[1] University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1991年 / 31卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1991.tb05584.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：627 / 634

页数：8

共 48 条

[1] INDIVIDUAL-RESPONSES TO CONVERTING ENZYME-INHIBITORS AND CALCIUM-ANTAGONISTS [J].

BIDIVILLE, J ;

NUSSBERGER, J ;

WAEBER, G ;

PORCHET, M ;

WAEBER, B ;

BRUNNER, HR .

HYPERTENSION, 1988, 11 (02) :166-173

[2] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[3]

Brunner H R, 1983, J Hypertens Suppl, V1, P103

[4]

BUHLER FR, 1982, J CARDIOVASC PHARM, V4, P5350

[5]

CODY RJ, 1983, HYPERTENSION, V5, P36

[6] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].

DAVIES, RO ;

GOMEZ, HJ ;

IRVIN, JD ;

WALKER, JF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229

[7] HUMORAL AND RENAL EFFECTS OF MK-421 (ENALAPRIL) IN HYPERTENSIVE SUBJECTS [J].

DELEEUW, PW ;

HOOGMA, RPLM ;

VANSOEST, GAW ;

TCHANG, PT ;

BIRKENHAGER, WH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (05) :731-736

[8] DEVELOPMENT OF PHARMACODYNAMIC TOLERANCE TO PRAZOSIN IN CONGESTIVE HEART-FAILURE [J].

DESCH, CE ;

MAGORIEN, RD ;

TRIFFON, DW ;

BLANFORD, MF ;

UNVERFERTH, DV ;

LEIER, CV .

AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (06) :1178-1182

[9]

DONNELLY R, 1990, BRIT J CLIN PHARMACO, V29, pP611

[10] KETANSERIN CONCENTRATION-EFFECT RELATIONSHIPS IN INDIVIDUAL HYPERTENSIVE PATIENTS [J].

DONNELLY, R ;

ELLIOTT, HL ;

MEREDITH, PA ;

HUGHES, DMA ;

REID, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (01) :61-64

← 1 2 3 4 5 →